553-53-7

应用筛选条件

关键词:'553-53-7'

显示 1-18 共 18 条结果关于 "553-53-7" 范围技术文档

Budavari, S., ed. (Merck & Co., 1996) #4911. 2. Supplier information. 3. Brockmann et al., Ann., 553, 1 (1942). 4. Takahashi, I. et al., Biochem. Biophys. Res. Commun., 165, 1207 (1989). 5. Zhang W

DataSheet - P0044

., 213(2), 193-195 (1996). 3. Runnegar, M.T. et al., J. Pharmacol. Exp. Ther., 273(1), 545-553 (1995). 4. Peirce, M.J. et al., Am. J. Physiol., 277(6), C1021-C1028 (1999). 5. Chan, Allan

Cholera Toxin B Subunit Peroxidase from Vibrio cholerae

or above 8. DO NOT FREEZE. References 1. Finkelstein, R.A., CRC Crit. Rev. Microbiol., 2, 553-623 (1973). 2. Finkelstein, R.A., et al., J. Immunol., 113, 145-150 (1974). 3. Gill, D.M.

XP725 Antibody Number-Lot Number 071M4826

a-b c-d e-f g-h a-b c-d e-f g-h 1.1 1 2 3 4 25 26 27 28 49 50 51 52 73 74 75 76 1.2 5 6 7 8 29 30 31 32 53 54 55 56 77 78

Data Sheet - 74188

, et al., Method. Enzymol., 1982, 83, 458. 30 M.J. Morin, et al., J. Biochem. Pharm., 1983, 32, 553. 31 W. McDowell, et al., Biochem. J., 1987, 248, 523. 32 V.N. Shibaev, Pure Appl. Chem., 1978

59505 Galactosyltransferase Kit

et al., Method. Enzymol., 1982, 83, 458. 30 M.J. Morin, et al., J. Biochem. Pharm., 1983, 32, 553. 31 W. McDowell, et al., Biochem. J., 1987, 248, 523. 32 V.N. Shibaev, Pure Appl. Chem.

inNovations Newsletter #14

Clarke, A. R. (1998) Transgenic Res. 7, 387–396. 3. Wagner, K. U., McAllister, K., Ward, T., Davis, B., Wiseman, R., and Hennighausen, L. (2001) Transgenic Res. 10, 545–553. 15 inNovations 14 Figure

Advanced Applications of Engineered Nanomaterials

Emission Range (nm) FWHM (nm) Size* (nm) Prod. No. Core-Shell LumidotTM CdSe/ZnS Nanopowder 553 545 - 555 36 2.5 5��1 Core-Shell LumidotTM CdSe/ZnS Nanopowder 562 560 - 570 35 2.6 �9�� Core-Shell

XP725 Antibody List Lot 129K4831

PERP P5243 64065 PERP P NP_071404.2 y n/d n/d 1 q/t T5942 546165 M y y y 94 N dher 553 g Parvin P5746 64098 PARVG M NP_001131077.1 y n/d n/d 594

XP725 Antibody List Lot 129K4830

PERP P5243 64065 PERP P NP_071404.2 y n/d n/d 1 q/t T5942 546165 M y y y 94 N dher 553 g Parvin P5746 64098 PARVG M NP_001131077.1 y n/d n/d 594

XP725 Antibody List Lot 089K4791

PERP P5243 64065 PERP P NP_071404.2 y n/d n/d 1 q/t T5942 546165 M y y y 94 N dher 553 g Parvin P5746 64098 PARVG M NP_001131077.1 y n/d n/d 594

XP725 Worksheet for Lot Number 071M4826

y 553 3 4 4 1 Filamin F1888 554 3 4 4 2 Filamin F1888 555 3 4 4 3 Filensin F1043 556 3 4 4 4 Filensin F1043 557 3 4 4 5 FKHR FOXO1a F6928 558 3 4 4 6 FKHR FOXO1a

List of Antibodies

Protein Kinase ζ P0713 P n/d y y 628 Rad17 R8029 P y n/d n/d 552 Anti Cy3+Cy5 C0992 M NA NA NA 553 γ Parvin P5746 M y n/d n/d 554 Parkin P6248 M y y y 555 PARP P7605

Biodiscover Whole Genome Amplification Advisor

dilution and multiple displacement amplification for molecular haplotyping, Biotechniques, 38(4), 553-9 (2005). 9. Ludecke HJ, Senger G, Claussen U, Horsthemke B. Cloning defined regions of the human

XP725 Antibody List

) P5367 5074, 64513, 114774 Pawr,PAWR NP_002574.2,NP_277020.1,NP_473397.1 P y y y 552 Anti Cy3+Cy5 553 γ Parvin P5746 64098 PARVG NP_071424.1 M y n/d n/d 554 Parkin P6248 5071, 50873, 56816 PARK2,Park2

XP725 Antibody List 013M4793

P5367 5074, 64513, 114774 Pawr,PAWR NP_002574.2,NP_277020.1,NP_473397.1 P y y y 552 Anti Cy3+Cy5 C0992 553 γ Parvin P5746 64098 PARVG NP_071424.1 M y n/d n/d 554 Parkin P6248 5071, 50873, 56816 PARK2,Park2

Halal Certificate

SUCCINATE 98% W327700 B73688 HC-23SI3Y60 552. DL-ALANINE 99%, FCC, FG W381810 A30662 HC-23SIEO56 553. DL-Menthol W266507 C29015 HC-23SIOJ95 554. DL-MENTHYL ACETATE 97%, FG W266809 C87825 HC-23SITV81

Halal Certificate

SUCCINATE 98% W327700 B73688 HC-22SICY81 552. DL-ALANINE 99%, FCC, FG W381810 A30662 HC-22SI4O77 553. DL-Menthol W266507 C29015 HC-22SIXV17 554. DL-MENTHYL ACETATE 97%, FG W266809 C87825 HC-22SI7V03